Issue 74, 2015

Novel contribution to the simultaneous analysis of certain hypoglycemic drugs in the presence of their impurities and degradation products utilizing UPLC-MS/MS

Abstract

A novel ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) method was established for simultaneous determination of three hypoglycemic drugs namely; sitagliptin (STG), vildagliptin (VLG) and metformin (MET) in the presence of their degradation products and STG related impurities. Chromatographic separation was accomplished on a Hypersil gold 50 mm × 2.1 mm (1.9 μm) column, using acetonitrile and 0.2% formic acid aqueous solution as the mobile phase with a gradient elution. Electrospray ionization (ESI) source was operated in the positive ion mode. The selected reaction monitoring (SRM) mode on a triple quadrupole mass spectrometer was used to quantify the drugs utilizing the transitions of 408.12 → 235.24 (m/z), 304.33 → 154.32 (m/z), 130.12 → 71.32 (m/z) and 255.75 → 166.15 (m/z), for STG, VLG, MET and diphenhydramine (IS), respectively. The method has displayed a lower limit of detection of 1.50 ng mL−1, 1.50 ng mL−1 and 3.00 ng mL−1 for STG, VLG and MET, respectively. The drugs were subjected to forced degradation where it was concluded that STG, VLG and MET were highly susceptible for alkaline stress conditions. In addition, the study of the degradation kinetics of the drugs has proved that the degradation follows a pseudo-first-order reaction. The proposed method was effectively applied for the analysis of laboratory prepared mixtures as well as combined pharmaceutical formulations. No significant difference was found regarding accuracy and precision upon statistical comparison of the obtained results with those of the reported method. Validation was conducted in compliance with the ICH guidelines proving the method to be selective, linear, precise and accurate. The simplicity and sensitivity of this method allows its use in the quality control of the cited drugs.

Graphical abstract: Novel contribution to the simultaneous analysis of certain hypoglycemic drugs in the presence of their impurities and degradation products utilizing UPLC-MS/MS

Article information

Article type
Paper
Submitted
15 Jun 2015
Accepted
03 Jul 2015
First published
06 Jul 2015

RSC Adv., 2015,5, 60467-60481

Novel contribution to the simultaneous analysis of certain hypoglycemic drugs in the presence of their impurities and degradation products utilizing UPLC-MS/MS

S. Mowaka and D. Mohamed, RSC Adv., 2015, 5, 60467 DOI: 10.1039/C5RA11448A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements